Dionna J. Green - Concepedia

Author

Dionna J. Green

United States Food and Drug Administration

Also Known As

Dionna J. Green

Publications

587

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration Center for Drug Evaluation and Research Children's National University of California San Diego University Children’s Hospital Basel

About

Dionna J. Green is an author at United States Food and Drug Administration specializing in medicine, pediatrics, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	251
2	Public Health	5	5	102
3	Education	1	1	22
4	Health Sciences	1	1	33
5	Social Sciences	1	1	49

Dionna J. Green

Publications

482

Citations

H-Index

Page 1

	Year	Citations
Adolescent Dosing and Labeling Since the Food and Drug Administration Amendments Act of 2007 Jeremiah D. Momper, Yeruk Mulugeta, Dionna J. Green, JAMA Pediatrics	2013	116
A Comparison of Pediatric and Adult Safety Studies for Antipsychotic and Antidepressant Drugs Submitted to the United States Food and Drug Administration Xiaomei I. Liu, Paul Schuette, Gilbert J. Burckart, The Journal of Pediatrics Drug SafetyPsychiatryMedicineAdult Safety StudiesPsychotropic Medication	2019	49
Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir Xiaomei I. Liu, Jeremiah D. Momper, Natella Rakhmanina, The Journal of Clinical Pharmacology	2019	46
Monoclonal Antibodies and Fc‐Fusion Proteins for Pediatric Use: Dosing, Immunogenicity, and Modeling and Simulation in Data Submitted to the US Food and Drug Administration Xiaomei I. Liu, André Dallmann, Yow‐Ming Wang, The Journal of Clinical Pharmacology ImmunohematologyAllergy MedicineImmunodeficienciesImmunologyImmunotherapy	2019	33
Pediatric Drug Development: Outlook for Science‐Based Innovation Dionna J. Green, Issam Zineh, Gilbert J. Burckart Clinical Pharmacology & Therapeutics	2018	31
Primary Endpoints in Pediatric Efficacy Trials Submitted to the US FDA Dionna J. Green, Janelle M. Burnham, Paul Schuette, The Journal of Clinical Pharmacology Clinical EndpointPediatric Efficacy TrialsAppropriate EndpointsPreventive PediatricsPediatric Epidemiology	2018	24
Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012–2018 Irin Tanaudommongkon, Shogo John Miyagi, Dionna J. Green, Clinical Pharmacology & Therapeutics Us FoodPre-clinical PharmacologyAdult TrialsTranslational MedicinePreventive Pediatrics	2020	24
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling Xiaomei I. Liu, Jeremiah D. Momper, Natella Rakhmanina, Clinical Pharmacokinetics Therapeutic Drug MonitoringPharmacokinetic ModelingPreclinical Drug EvaluationRaltegravir Using PhysiologicallyPhysiologically-based Pharmacokinetic Modeling	2020	23
Obesity and Pediatric Drug Development Janelle D. Vaughns, Laurie S. Conklin, Panli Zheng, The Journal of Clinical Pharmacology Weight ManagementObesityMetabolic SyndromeClinical EpidemiologyDrug Monitoring	2018	22
Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir Xiaomei I. Liu, Jeremiah D. Momper, Natella Rakhmanina, Clinical Pharmacokinetics Predict Neonatal PharmacokineticsNeonatologyPharmacokinetic ModelingPhysiologically-based Pharmacokinetic ModelingPharmacology	2021	22

Page 1